SCHEMBL30879248

SCHEMBL30879248

CN1CCN(c2ccc([N+](=O)[O-])cc2S(=O)(=O)NCC2CCCC2)CC1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.56
▸ CYP1A2 P05177 4/20 0.56
▸ CYP3A4 P08684 4/20 0.56
▸ CYP2C19 P33261 4/20 0.56
▸ SMN1; SMN2 Q16637 3/20 0.56
▸ HTT P42858 2/20 0.56
▸ CYP2C9 P11712 3/20 0.48
▸ CYP2D6 P10635 2/20 0.48
▸ MCOLN3 Q8TDD5 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.47
▸ GAA P10253 3/20 0.46
▸ WDR5 P61964 4/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ POLB P06746 1/20 0.44
▸ LMNA P02545 4/20 0.43
▸ PKM P14618 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ NPY1R P25929 1/20 0.42
▸ NPY5R Q15761 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30879071 0.83 NSD2 (0.48) ALDH1A1SMN1; SMN2NPSR1GAAKMT2A
SCHEMBL10126983 0.81 HTT (0.64) ALDH1A1CYP1A2CYP3A4CYP2C19SMN1; SMN2
SCHEMBL30878986 0.80 HTT (0.55) ALDH1A1CYP1A2CYP3A4CYP2C19SMN1; SMN2
SCHEMBL30921338 0.78 WDR5 (0.54) ALDH1A1HTTCYP2D6GAAWDR5
SCHEMBL30879299 0.78 KMT2A (0.44) ALDH1A1KMT2APOLBMEN1NPY1R
SCHEMBL30878757 0.77 ALDH1A1 (0.76) ALDH1A1CYP1A2CYP3A4CYP2C19SMN1; SMN2
SCHEMBL15486931 0.76 HTT (0.67) ALDH1A1CYP1A2CYP3A4CYP2C19SMN1; SMN2
SCHEMBL30879164 0.74 CYP19A1 (0.54) ALDH1A1CYP1A2CYP3A4CYP2C19SMN1; SMN2
SCHEMBL30879141 0.73 WDR5 (0.61) ALDH1A1HTTCYP2D6GAAWDR5
SCHEMBL29354408 0.73 ALDH1A1 (0.58) ALDH1A1CYP1A2CYP3A4CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 — — EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 — — WO disclosed
Send feedback